Pigment International (Jan 2021)

Serpentine Supravenous Hyperpigmentation Following Intravenous Docetaxel

  • Satarupa Mondal,
  • Avik Panigrahi,
  • Dibyendu Bikash Bhanja,
  • Sayantani Chakraborty,
  • Abheek Sil

DOI
https://doi.org/10.4103/Pigmentinternational.Pigmentinternational_10_20
Journal volume & issue
Vol. 8, no. 2
pp. 109 – 111

Abstract

Read online

Serpentine supravenous hyperpigmentation is a rare, cutaneous sequela of intravenous chemotherapeutic agents, collagen vascular diseases (systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis), and infections like leprosy and HIV. The condition manifests clinically as a peculiar, patterned eruption characterized by hyperpigmented streaks following the superficial venous network on the skin. Here, we report a case of a middle-aged lady with breast carcinoma, who developed serpentine supravenous hyperpigmentation after intravenous docetaxel.

Keywords